ODYS— Odysight.ai Inc.

Health Care$74M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
REVENUES	$3.0M-23.9%	$4.0M+30.7%	$3.0M+356.1%	$665K
COST OF REVENUES	$2.1M-23.6%	$2.8M+11.2%	$2.5M+54.8%	$1.6M
GROSS PROFIT	$871K-24.7%	$1.2M+127.3%	$509K+152.7%	-$966K
RESEARCH AND DEVELOPMENT EXPENSES	$9.6M+40.0%	$6.9M+22.9%	$5.6M+33.5%	$4.2M
SALES AND MARKETING EXPENSES	$2.3M+91.1%	$1.2M+9.8%	$1.1M+58.7%	$699K
GENERAL AND ADMINISTRATIVE EXPENSES	$7.0M+26.6%	$5.6M+25.5%	$4.4M+23.9%	$3.6M
OPERATING LOSS	-$18.1M-45.0%	-$12.5M-17.6%	-$10.6M-12.6%	-$9.4M
FINANCING INCOME, NET	$1.1M+48.6%	$740K-25.1%	$988K	—
NET LOSS	-$17.0M-44.8%	-$11.8M-24.6%	-$9.4M+0.2%	-$9.5M
Net loss per share basic	-$1070.00-3.9%	-$1030.00-5.1%	-$980.00+26.3%	-$1330.00
Net loss per share diluted	-$1070.00-3.9%	-$1030.00-5.1%	-$980.00+26.3%	-$1330.00
Weighted average common shares basic	15.9M+38.9%	11.4M+18.4%	9.7M+35.7%	7.1M
Weighted average common shares diluted	15.9M+38.9%	11.4M+18.4%	9.7M+35.7%	7.1M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 11 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.